Sunshine Biopharma (SBFM) Earnings Date, Estimates & Call Transcripts → Controversial CEO explains new way to amass wealth (From Stansberry Research) (Ad) Free SBFM Stock Alerts $0.99 +0.15 (+17.86%) (As of 05/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 8EstimatedActual EPS (Mar. 28) -$5.00 Missed By -$5.00 Get Sunshine Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for SBFM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSBFM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SBFM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchControversial CEO explains new way to amass wealthThere's no shortage of controversial CEOs in America today... From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon... But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1...Don't miss Porter's brand-new presentation on this subject SBFM Earnings Date and InformationSunshine Biopharma last posted its quarterly earnings data on March 28th, 2024. The reported ($5.00) earnings per share for the quarter. The business earned $7.68 million during the quarter. Sunshine Biopharma has generated ($19.00) earnings per share over the last year (($19.00) diluted earnings per share). Sunshine Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.Read More Sunshine Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Estimated)------- 3/28/2024Q4 2023-($5.00)($5.00)($5.00)-$7.68 million11/13/2023Q3 2023($6.00)($4.00)+$2.00($0.04)-$5.96 million8/11/2023Q2 2023-($2.00)($2.00)($0.02)-$5.56 million5/10/2023Q1 2023-($8.00)($8.00)($0.08)-$4.89 million4/4/2023Q4 2022-($150.00)($150.00)($1.50)-$3.94 million11/7/2022Q3 2022-($8.00)($8.00)($0.08)-$0.13 million Get the Latest News and Ratings for SBFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022-($3.00)($3.00)($0.03)-$0.15 million5/6/2022Q1 2022-($23.00)($23.00)($0.23)-$0.12 million11/9/2021Q3 2021-($1.00)($1.00)($0.01)-$0.05 million8/9/2021Q2 2021-($1.00)($1.00)($0.01)-$0.05 million5/11/2021Q1 2021-($1.00)($1.00)($0.01)-$0.04 million Sunshine Biopharma Earnings - Frequently Asked Questions When is Sunshine Biopharma's earnings date? Sunshine Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on SBFM's earnings history. How much revenue does Sunshine Biopharma generate each year? Sunshine Biopharma (NASDAQ:SBFM) has a recorded annual revenue of $24.09 million. How much profit does Sunshine Biopharma generate each year? Sunshine Biopharma (NASDAQ:SBFM) has a recorded net income of -$4.51 million. SBFM has generated -$19.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Evelo Biosciences Earnings Evofem Biosciences Earnings Bellerophon Therapeutics Earnings Aditxt Earnings Comera Life Sciences Earnings GRI Bio Earnings Athersys Earnings Aptevo Therapeutics Earnings Ampio Pharmaceuticals Earnings Lucy Scientific Discovery Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:SBFM) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.